Applied Launches FDA Drug Reporting Service
The new drug reporting service helps transfillers meet the new FDA requirement to report the amount of medical oxygen filled and released to patients annually.
Applied Home Healthcare Equipment has launched a new drug reporting service that helps drug manufacturers (transfillers) know they are meeting the FDA’s new requirement to report the amount of medical oxygen filled and released to patients annually.
The reported data will also improve FDA’s visibility into the drug supply chain and help the agency identify, prevent, and mitigate drug shortages.
Reports for calendar year 2020 should be submitted no later than Feb. 15, 2022, and reports for calendar year 2021 should be submitted no later than May 16, 2022.
“The new drug reporting service we’re offering takes the worry out of annual reporting for our transfillers,” said Jim Christ, general manager of Applied Home Healthcare Equipment. “Many providers are confused on how to and what to provide to the FDA, so we are offering this service to make it as easy as possible.”
The new drug reporting service will expand on the FDA registration and drug listing service currently offered by Applied’s FDA registration department, and is offered for 2020, 2021, or both years for a discounted price.